VR Logo

Zivo Bioscience Inc. (ZIVO) download report


Healthcare | Biotechnology & Pharma Research

Zivo Bioscience Inc. (ZIVO) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers.

IPO Date: 24-Sep-2012

Pres, CEO & Chairman: Mr. John B. Payne

CFO, Treasurer & Sec.: Mr. Keith R. Marchiando

Listing: NASDAQ: ZIVO

Country: United States

Headquarters: Bloomfield Hills, MI

Website: https://www.zivobioscience.com

Key Facts

Market cap: $28.73 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-9.32 Mln

Cash: $8.90 Mln

Total Debt: $0.00 Mln

Insider's Holding: 33.26%

Liquidity: Low

52 Week range: $2.37 - 7.90

Shares outstanding: 9,419,660

10 Years Aggregate:

  • CFO: $-34.68 Mln
  • EBITDA: $-9,098.79 Mln
  • Net Profit: $-9,233.17 Mln

Stock Performance

Time Period Zivo Bioscience (ZIVO) S&P BSE Sensex S&P Small-Cap 600
YTD23.34-9.49-17.79
1 month28.26-2.87-2.72
3 months-9.23-8.59-12.17
1 Year-19.910.81-15.82
3 Years223.0510.397.14
5 Years123.1311.116.20
10 Years33.4912.0010.33
As on 24-Jun-2022
Year Zivo Bioscience (ZIVO) S&P Small-Cap 600 S&P BSE Sensex
20211,813.3325.2721.99
2020-9.099.5715.75
201926.9220.8614.38
201837.18-9.705.87
2017-0.4211.7327.91
201665.2224.741.95
2015-27.22-3.36-5.03